Skip to main content

Month: September 2020

Immune Health Supplements Market Exhibit 7.4% CAGR and Reach USD 29.40 Billion 2027; Rapid Changes in Lifestyles to Bolster Growth, says Fortune Business Insights™

Pune, Sept. 23, 2020 (GLOBE NEWSWIRE) — The global immune health supplements market is likely to grow astonishingly backed by the increasing popularity of non-GMO and organic ingredients amongst the masses. The trend is further resulting in the rising purchase of organic immunity health supplements worldwide. The report further states that the immune health supplements market size was USD 16.32 billion in 2019 and is projected to reach USD 29.40 billion by 2027, exhibiting a CAGR of 7.4% during the forecast period.This Report Answers the Following Questions:Which are the market drivers, hindrances, and dynamics?Will the companies adopt new strategies to compete in the market?Which segment is expected to dominate the market in terms of share?How will COVID-19 help in generating more sales of immune health supplements?Request a Sample...

Continue reading

Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD

LONDON and RALEIGH, N.C., Sept. 23, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of its ENHANCE (“Ensifentrine as a Novel inHAled Nebulized COPD thErapy”) Phase 3 trials to evaluate the efficacy and safety of nebulized ensifentrine in patients with moderate to severe chronic obstructive pulmonary disease (“COPD”).David Zaccardelli, Pharm. D., President and CEO of Verona Pharma, said: “We are excited to start our pivotal ENHANCE Phase 3 studies. If successful, the data will support the submission of a New Drug Application in the U.S. for nebulized ensifentrine for the maintenance treatment of COPD. This is an important milestone for Verona Pharma and we look forward to addressing the urgent...

Continue reading

Landsvirkjun successfully issues Green Bonds in the US Private Placement market

Among the first companies globally to adopt a new approach to finance green assetsLandsvirkjun has today signed an agreement with US and UK institutional investors to issue USD 150 million senior unsecured notes in the US Private Placement (“USPP”) market in Green Bond format. The notes have been issued under the company’s updated Green Finance Framework (“GFF”) with proceeds to be used to finance and refinance green assets on the company’s balance sheet. Landsvirkjun is among the first companies globally to apply this new balance sheet approach in its GFF. The notes are issued without a state guarantee of collection.The offering was very well received, with the order book totalling USD 545 million, representing over 5x oversubscription from the launch size of USD 100 million. The notes have a 9-year maturity and carry a fixed interest...

Continue reading

Landsvirkjun gefur út græn skuldabréf á Bandaríkjamarkaði

Á meðal fyrstu fyrirtækja í heiminum til að beita nýrri nálgun við fjármögnun grænna eignaLandsvirkjun hefur skrifað undir samning við bandaríska og breska fagfjárfesta um útgáfu grænna skuldabréfa. Um var að ræða lokað skuldabréfaútboð á Bandaríkjamarkaði (e. US private placement), að fjárhæð samtals 150 milljónir Bandaríkjadala, jafnvirði um 21 milljarðs íslenskra króna. Bréfin eru gefin út undir uppfærðum grænum fjármögnunarramma Landsvirkjunar („Green Finance Framework“). Fjármunirnir verða nýttir til að fjármagna og endurfjármagna grænar eignir á efnahagsreikningi fyrirtækisins. Það er ný nálgun í skilgreiningu á ráðstöfun fjármuna samkvæmt græna fjármögnunarrammanum og er Landsvirkjun á meðal fyrstu fyrirtækja á heimsvísu sem beita þessari nýju nálgun. Bréfin eru gefin út án ríkisábyrgðar.Upphaflega var stefnt að skuldabréfaútgáfu...

Continue reading

INGENICO GROUP: Ingenico Group receives the EcoVadis Platinum medal for its CSR performance and joins the top 1 percent of assessed companies

Ingenico Group receives the EcoVadis Platinum medal for its CSR performance and joins the top 1 percent of assessed companiesIngenico Group (Euronext: FR0000125346 – ING), the global leader in seamless payments is proud to receive the Platinum EcoVadis Medal, the highest distinction awarded by the independent platform that assesses companies’ social and environmental performance. This year, with a 4-point improvement on its previous year, Ingenico reaches the global score of 74/100, placing the Group among the top 1 percent of companies assessed by EcoVadis.This progression1 confirms Ingenico’s long term commitment to promoting Corporate Social Responsibility (CSR) within the Group, relying on its dedicated “SHARE2” programme. This 5-year plan follows on from the measures already initiated by the Group in 2015 and is based around...

Continue reading

INGENICO GROUP : Ingenico Group reçoit la médaille Platine d’EcoVadis pour sa performance RSE et rejoint le top 1 % des entreprises évaluées

Ingenico Group reçoit la médaille Platine d’EcoVadis pour sa performance RSE et rejoint le top 1 % des entreprises évaluéesIngenico Group (Euronext: FR0000125346 – ING), leader mondial des solutions de paiement intégrées, est fier d’obtenir la médaille Platine EcoVadis, la plus haute distinction décernée par la plate-forme indépendante d’évaluation des performances sociale et environnementale des entreprises. Cette année, Ingenico améliore de 4 points sa note avec un score global de 74/100 et rejoint le top 1 % des entreprises évaluées par EcoVadis.  Cette nouvelle progression1 vient confirmer l’engagement d’Ingenico depuis plusieurs années en matière de Responsabilité Sociétale de l’Entreprise (RSE), qui s’appuie sur son programme dédié « SHARE2 ». Ce plan à cinq ans s’inscrit dans le prolongement des actions initiées depuis...

Continue reading

CENTOGENE Opens Walk-In COVID-19 Testing Facility at Düsseldorf Airport

CENTOGENE expands its SARS-CoV-2 testing solution to Düsseldorf Airport after successfully launching walk-in COVID-19 test facilities at Frankfurt and Hamburg AirportCompany’s PCR tests now available for passengers departing from or arriving at Düsseldorf Airport, as well as to the general publicExpansion of testing to Düsseldorf Airport further paves the way towards a new normal for our communities and economiesCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 23, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, announced today the opening of its new COVID-19 testing facility at Düsseldorf Airport.CENTOGENE now also provides its test...

Continue reading

Aktia’s financial calendar and Annual General Meeting in 2021

Aktia Bank PlcStock Exchange Release23 September 2020 at 10.00 a.m.Aktia’s financial calendar and Annual General Meeting in 2021Accounts Announcement 2020Aktia Bank Plc publishes its Accounts Announcement for 2020 on Thursday 18 February 2021.Annual Report 2020Aktia Bank Plc’s Annual Report 2020 will be published week 12 at the latest.Annual General Meeting of Shareholders 2021Aktia Bank Plc’s Annual General Meeting of Shareholders is planned to be held on Tuesday 13 April 2021.Interim Reports 2021Interim Report January–March 2021: Wednesday 5 May 2021Half-year Report January–June 2021: Thursday 5 August 2021Interim Report January–September 2021: Thursday 4 November 2021Aktia Bank PlcFurther information:Lotta Borgström, Director, Investor Relations and Communications, tel. +358 10 247 6838, lotta.borgstrom@aktia.fiDistribution:Nasdaq...

Continue reading

Aktian taloudellinen kalenteri ja yhtiökokous vuonna 2021

Aktia Pankki Oyj Pörssitiedote23.9.2020 klo 10.00Aktian taloudellinen kalenteri ja yhtiökokous vuonna 2021Tilinpäätöstiedote 2020Aktia Pankki Oyj julkaisee tilinpäätöstiedotteensa vuodelta 2020 torstaina 18. helmikuuta 2021.Vuosikertomus 2020Aktia Pankki Oyj:n vuosikertomus 2020 julkaistaan viimeistään viikolla 12.Varsinainen yhtiökokous 2021Aktia Pankki Oyj:n varsinainen yhtiökokous suunnitellaan pidettävän tiistaina 13. huhtikuuta 2021.Osavuosikatsaukset 2021Osavuosikatsaus tammi–maaliskuu 2021: keskiviikkona 5. toukokuuta 2021Puolivuosikatsaus tammi–kesäkuu 2021: torstaina 5. elokuuta 2021Osavuosikatsaus tammi–syyskuu 2021: torstaina 4. marraskuuta 2021Aktia Pankki OyjLisätietoja:Lotta Borgström, sijoittajasuhde- ja viestintäjohtaja, puh. 010 247 6838, lotta.borgstrom@aktia.fiJakelu:Nasdaq Helsinki OyTiedotusvälineetwww.aktia.comAktia...

Continue reading

Aktias finansiella kalender och bolagsstämma år 2021

Aktia Bank AbpBörsmeddelande23.9.2020 kl. 10.00Aktias finansiella kalender och bolagsstämma år 2021Bokslutskommuniké 2020Aktia Bank Abp publicerar sin bokslutskommuniké för 2020 torsdagen den 18 februari 2021.Årsredovisning 2020Aktia Bank Abp:s årsredovisning 2020 publiceras senast vecka 12.Ordinarie bolagsstämma 2021Aktia Bank Abp:s ordinarie bolagsstämma planeras hållas tisdagen den 13 april 2021.Delårsrapporterna 2021Delårsrapport januari–mars 2021: onsdagen den 5 maj 2021Halvårsrapport januari–juni 2021: torsdagen den 5 augusti 2021Delårsrapport januari–september 2021: torsdagen den 4 november 2021Aktia Bank AbpMera information:Lotta Borgström, direktör för investerarrelationer och kommunikation, tfn 010 247 6838, lotta.borgstrom@aktia.fiDistribution:Nasdaq Helsinki OyMassmedierwww.aktia.comAktia är en finländsk kapitalförvaltare,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.